Chest pain of esophageal origin or noncardiac chest pain is reported by at
least a fifth of the general population. Recent literature focused on furth
er understanding mechanisms of chest pain in subset of patients with functi
onal chest pain of presumed esophageal origin. Studies have demonstrated co
ncurrent visceral and somatic pain hypersensitivity, and amplified secondar
y allodynia, in patients with noncardiac chest pain (NCCP), suggesting cent
ral sensitization. Other studies have demonstrated abnormal cerebral proces
sing of intraesophageal stimuli. However, gastroesophageal reflux disease (
GERD) has remained the most common esophageal cause of NCCP. The introducti
on of the proton pump inhibitor test, a highly sensitive and cost-effective
diagnostic strategy, simplified our diagnostic approach toward patients wi
th GERD-related NCCP. For patients with positive proton-pump-inhibitor test
results, long-term treatment with antireflux medication is warranted. For
patients with non-GERD-related NCCP, pain modulators remain the cornerstone
of therapy.